David A. Siegel Accolade, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Accolade, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 194,800 shares of ACCD stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
194,800
Previous 46,100
322.56%
Holding current value
$1.35 Million
Previous $177,000
276.27%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ACCD
# of Institutions
172Shares Held
62.4MCall Options Held
27.3KPut Options Held
1.36M-
Black Rock Inc. New York, NY6.16MShares$42.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.66MShares$32.3 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.18MShares$29 Million0.0% of portfolio
-
Ah Equity Partners Iv (Parallel), L.L.C. Menlo Park, CA3.78MShares$26.2 Million88.81% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.48MShares$24.1 Million0.29% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $499M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...